Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Dr. Falk Pharma GmbH"
Count: 44
Selected: 0
NCT05083390Norursodeoxycholic Acid vs. Placebo in NASH
NCT05488405Mesalazine Oral Suspension in Active Eosinophilic Esophagitis
NCT05621811Different Doses of Naronapride vs. Placebo in Gastroparesis
NCT05305599Different Doses of ZED1227 vs. Placebo in NAFLD
NCT02493335Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis
NCT02142634Budesonide for Induction of Remission in Incomplete Microscopic Colitis
NCT00746486Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
NCT02280629Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)
NCT03872921norUrsodeoxycholic Acid vs Placebo in PSC
NCT01966783Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis
NCT01510860Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis
NCT00838214Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis
NCT00529009Pharmacokinetic Investigation of UDCA in Bile and Serum
NCT01208922Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
NCT02550418Budesonide 9 mg Capsules in Active UC
NCT01847664Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis
NCT01209208Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
NCT00695643Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis
NCT01038739Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis
NCT02142725Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis
NCT02434029Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis
NCT01755507Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
NCT01745770TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)
NCT02280616Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis
NCT01627262Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study
NCT01278082SOIBD Collagenous Colitis Maintenance Study
NCT00887263Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)
NCT00449722OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
NCT01279577Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease
NCT010865539 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease
NCT00450086Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
NCT00300118Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)
NCT00946946Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine
NCT00747110Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)
NCT00746447Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC)
NCT00828230Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis
NCT03844932A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
NCT01882088Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD
NCT00180089Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation
NCT00180050Budesonide Treatment for Lymphocytic Colitis
NCT00285597Ursodeoxycholic Acid in Chronic Heart Failure
NCT00128739Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation
NCT00338910Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers
NCT00161083UDCA for Symptomatic Gallstone Disease